Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis

Allergy. 2024 Oct;79(10):2858-2861. doi: 10.1111/all.16189. Epub 2024 Jun 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Chronic Disease
  • Eosinophils* / immunology
  • Female
  • Humans
  • Immunoglobulin E* / blood
  • Immunoglobulin E* / immunology
  • Leukocyte Count
  • Male
  • Middle Aged
  • Nasal Polyps* / blood
  • Nasal Polyps* / drug therapy
  • Nasal Polyps* / immunology
  • Rhinitis* / blood
  • Rhinitis* / drug therapy
  • Rhinitis* / immunology
  • Rhinosinusitis
  • Sinusitis* / blood
  • Sinusitis* / drug therapy
  • Sinusitis* / immunology
  • Treatment Outcome

Substances

  • Immunoglobulin E
  • dupilumab
  • Antibodies, Monoclonal, Humanized

Grants and funding